SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

72,369.85 776.61
( 1.08%)

Global Indices

Nasdaq

51,245.91 45.04
(0.09%)

Dow Jones

7,786.38 -36.39
(-0.47%)

Hang Seng

69,343.08 -692.63
(-0.99%)

Nikkei 225

10,441.54 -16.96
(-0.16%)

Forex

USD-INR

96.67 0.30
(0.31%)

EUR-INR

108.31 -0.02
(-0.02%)

GBP-INR

127.86 0.18
(0.14%)

JPY-INR

0.61 0.00
(0.24%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Take Ltd

Industry : Miscellaneous

BSE Code

ISIN Demat

Book Value()

532890

INE142I01023

1.9257101

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

TAKE

32.79

189.21

EPS(TTM)

Face Value()

Div & Yield %

0.39

Back

Glaxosmithkline Pharmaceuticals consolidated net profit rises 15.69% in the June 2026 quarter

Aug 03,2026

Net profit of Glaxosmithkline Pharmaceuticals rose 15.69% to Rs 237.18 crore in the quarter ended June 2026 as against Rs 205.01 crore during the previous quarter ended June 2025. Sales rose 16.55% to Rs 938.44 crore in the quarter ended June 2026 as against Rs 805.17 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	938.44	805.17	17
OPM %	31.49	31.20	-
PBDT	338.29	294.50	15
PBT	322.45	278.98	16
NP	237.18	205.01	16

72,369.85 776.61 ( 1.08%)

51,245.91 45.04 (0.09%)

7,786.38 -36.39 (-0.47%)

69,343.08 -692.63 (-0.99%)

10,441.54 -16.96 (-0.16%)

96.67 0.30 (0.31%)

108.31 -0.02 (-0.02%)

127.86 0.18 (0.14%)

0.61 0.00 (0.24%)